PYPB.F IXICO PLC LS -01

Healthcare Biotechnology Frankfurt Exchange
0.1450 EUR
Close of Nov 12, 2026
0.0655 0.1780
Market cap
EUR 31.8M
P/E
-
P/B
2.48x
ROE
-14.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2025.

Is PYPB.F undervalued?

Graham number

The Graham number of IXICO PLC LS -01 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

IXICO PLC LS -01 fundamental analysis

No fundamental analysis for IXICO PLC LS -01 yet.

IXICO PLC LS -01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About IXICO PLC LS -01

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such…

Full company profile